GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Cyclically Adjusted PS Ratio

Biofarm (BSE:BIO) Cyclically Adjusted PS Ratio : 2.90 (As of Jan. 18, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Biofarm Cyclically Adjusted PS Ratio?

As of today (2025-01-18), Biofarm's current share price is lei0.724. Biofarm's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was lei0.25. Biofarm's Cyclically Adjusted PS Ratio for today is 2.90.

The historical rank and industry rank for Biofarm's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSE:BIO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.18   Med: 2.68   Max: 3.51
Current: 2.88

During the past years, Biofarm's highest Cyclically Adjusted PS Ratio was 3.51. The lowest was 2.18. And the median was 2.68.

BSE:BIO's Cyclically Adjusted PS Ratio is ranked worse than
60% of 640 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs BSE:BIO: 2.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biofarm's adjusted revenue per share data for the three months ended in Sep. 2024 was lei0.091. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is lei0.25 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofarm Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Biofarm's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Cyclically Adjusted PS Ratio Chart

Biofarm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.41 2.32 2.85

Biofarm Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 2.85 2.77 2.89 3.08

Competitive Comparison of Biofarm's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofarm's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biofarm's Cyclically Adjusted PS Ratio falls into.



Biofarm Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Biofarm's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.724/0.25
=2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofarm's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Biofarm's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.091/133.0289*133.0289
=0.091

Current CPI (Sep. 2024) = 133.0289.

Biofarm Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.040 99.070 0.054
201503 0.046 99.621 0.061
201506 0.022 100.684 0.029
201509 0.034 100.392 0.045
201512 0.042 99.792 0.056
201603 0.035 100.470 0.046
201606 0.035 101.688 0.046
201609 0.038 101.861 0.050
201612 0.046 101.863 0.060
201703 0.038 102.862 0.049
201706 0.045 103.349 0.058
201709 0.040 104.136 0.051
201712 0.049 104.011 0.063
201803 0.044 105.290 0.056
201806 0.040 106.317 0.050
201809 0.048 106.507 0.060
201812 0.054 105.998 0.068
201903 0.049 107.251 0.061
201906 0.046 108.070 0.057
201909 0.042 108.329 0.052
201912 0.061 108.420 0.075
202003 0.065 108.902 0.079
202006 0.040 108.767 0.049
202009 0.051 109.815 0.062
202012 0.064 109.897 0.077
202103 0.063 111.754 0.075
202106 0.056 114.631 0.065
202109 0.062 115.734 0.071
202112 0.061 117.630 0.069
202203 0.077 121.301 0.084
202206 0.064 125.017 0.068
202209 0.071 125.227 0.075
202212 0.069 125.222 0.073
202303 0.097 127.348 0.101
202306 0.067 128.729 0.069
202309 0.068 129.860 0.070
202312 0.052 129.419 0.053
202403 0.073 131.776 0.074
202406 0.071 132.554 0.071
202409 0.091 133.029 0.091

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biofarm  (BSE:BIO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Biofarm Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Biofarm's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofarm Business Description

Industry
Traded in Other Exchanges
N/A
Address
99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.